# D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

> **NCT00083876** · PHASE3 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 500 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT00083876
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 500 (—)
- **Last updated:** 2010-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083876, "D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00083876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*